NASDAQ

First Trust Nasdaq Pharmaceuticals ETF (FTXH)

399 Thanks from members

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) demonstrates strong short- to medium-term alpha and a favorable low-volatility risk profile compared to the broader health sector, despite structural long-cycle drag and intense drug-pricing headline exposure.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →